<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02114957</url>
  </required_header>
  <id_info>
    <org_study_id>A12-3742</org_study_id>
    <nct_id>NCT02114957</nct_id>
  </id_info>
  <brief_title>Pharmacokinetics of Decursin/Decursinol Angelate (CognIQTM)</brief_title>
  <official_title>Single Oral Dose Pharmacokinetics of Decursin/Decursinol Angelate in Healthy Adult Men and Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Texas Tech University Health Sciences Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Texas Tech University Health Sciences Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to investigate how human bodies absorb and metabolize two herbal drugs. The
      information is critical for drug development and could not be obtained from any other studies
      using animals. The two herbal drugs are decursin and decursinol angelate (DA) which naturally
      exist in a traditional herb Angelica gigas Nakai (AGN). Preclinical and clinical studies
      indicated that AGN and decursin/DA were quite safe to animals and human.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Area under the plasma concentration versus time curve (AUC) of decursin, decursinol angelate (DA) and decursinol</measure>
    <time_frame>0, 0.5, 1, 2, 3, 4, 6, 8, 12 , 24, 48 hours post‐dose</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>vital signs, plasma biochemistry and blood cell counts of subjects after consumption the study herb</measure>
    <time_frame>0 and 24 hours post-dose</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>study herb</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>800mg dietary supplement CognIQTM (4 capsules) by oral at hour 0</intervention_name>
    <arm_group_label>study herb</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Health subjects weighing between 50 to 91 kilograms (110 to 200 pounds)

          -  Subjects 18 to 65 years of age

          -  Subjects having normal hepatic, renal and bone marrow function as assessed by history,
             physical and clinical chemistry analysis

        Exclusion Criteria:

          -  Subjects positive for HIV, HBV and HCV

          -  Subjects with diabetes—due to length of fasting

          -  Subjects regularly taking any kind of prescription medications

          -  Subjects taking oral contraception, hormone-containing IUDs, contraception implants,
             or Depo medroxyprogesterone injections

          -  Subjects taking any food or herbal supplements containing AGN (e.g. CognIQTM,
             D-Cursinol, Decursinol-50™, Ache Action™, Fast-Acting Joint Formula, EstroG-100™)
             within 30 days of the study.

          -  Female subjects that are pregnant, &lt;6 months postpartum, or breastfeeding women.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jinhui Zhang, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Texas Tech University Health Sciences Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinical Research Unit, School of Medicine, Texas Tech University Health Sciences Center</name>
      <address>
        <city>Amarillo</city>
        <state>Texas</state>
        <zip>79106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 11, 2014</study_first_submitted>
  <study_first_submitted_qc>April 14, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 15, 2014</study_first_posted>
  <last_update_submitted>April 14, 2014</last_update_submitted>
  <last_update_submitted_qc>April 14, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 15, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>bio-availability</keyword>
  <keyword>decursin</keyword>
  <keyword>decursinol angelate</keyword>
  <keyword>decursinol</keyword>
  <keyword>subjects</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

